Mitogen-Activated Protein Kinase Kinase 1 Inhibitors [MoA] - N0000193943

Pharmacologic Class Information

Pharmacologic Code N0000193943
Pharmacologic Name Mitogen-Activated Protein Kinase Kinase 1 Inhibitors
Pharmacologic Uses
  • kinase inhibitor
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Mitogen-Activated Protein Kinase Kinase 1 Inhibitors

The table contains 2 products whose active ingredient are classified under the same pharmacologic class Mitogen-Activated Protein Kinase Kinase 1 Inhibitors [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0310-0625Koselugo Non-Proprietary Name: SelumetinibCapsuleOralAstrazeneca Pharmaceuticals LpACTIVE
0310-0610Koselugo Non-Proprietary Name: SelumetinibCapsuleOralAstrazeneca Pharmaceuticals LpACTIVE